ATM Equity Purchases by Pulse Biosciences Co-Chairmen Total Approximately $13.3 Million
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary nanosecond pulsed field ablation (nsPFA) energy, today announced its Co-Chairmen of the Board, Robert Duggan...